Ειδήσεις: ELI LILLY | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

31/03 14:53 investing.com

Alkermes stock surges 13% on Lilly sleep disorder deal

Alkermes Eli Lilly sleep disorder stock surge neuropsychiatric therapeutics partnership

31/03 14:29 statnews.com

STAT+: Eli Lilly to buy Centessa Pharmaceuticals, maker of a narcolepsy drug, in $6.3B deal

Eli Lilly Centessa Pharmaceuticals acquisition narcolepsy drug $6.3B premium

31/03 14:18 investing.com

Centessa shares surge after Lilly unveils $6.3 billion takeover deal

Centessa Eli Lilly takeover $6.3B oncology shares

31/03 10:30 defenseworld.net

Eli Lilly and Company (NYSE:LLY) Given New $1,163.00 Price Target at Guggenheim

Eli Lilly price target Guggenheim JPMorgan buy rating stock analysis

30/03 17:00 entrepreneur.com

Pharma Giant Eli Lilly Is Paying $2.75 Billion for Drugs Designed by AI – Here’s What It Gets Them

Eli Lilly AI drug design pharmaceutical acquisition research acceleration biotech investment drug development

30/03 16:34 statnews.com

STAT+: Biogen lupus drug improves skin clearance in mid-stage study

Biogen lupus skin clearance Insilico Medicine Eli Lilly AI drug discovery

30/03 16:31 yahoo.com

Eli Lilly and Company (LLY) Continued to Gain from Its Incretin Portfolio

Eli Lilly incretin GLP‑1 diabetes obesity stock performance

30/03 13:37 defenseworld.net

Mather Group LLC. Purchases 2,250 Shares of Eli Lilly and Company $LLY

Mather Group Eli Lilly share purchase institutional investor Vermillion White Wealth Q4 holdings

30/03 08:04 investing.com

Eli Lilly demands higher NHS drug prices to resume UK investment - report

Eli Lilly NHS drug pricing UK investment pharmaceutical reimbursement healthcare policy

30/03 08:04 investing.com

Eli Lilly demands higher NHS drug prices to resume UK investment - report

Eli Lilly NHS drug pricing UK investment pharmaceutical reimbursement healthcare policy

Loading...